InsiderClue
Stocks · Health care · Pharmaceutical Preparations

PUMA BIOTECHNOLOGY, INC.

PBYI Clue Score62
United States Fiscal year ends December CIK 0001401667 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

17
Insider
Date
Role
Action
Shares
Price
Amount
Alessandra Cesano
14 Sep 2026
Director
Sold after exercise
62,150
$9.12
$566.99K
Troy Edward Wilson
14 Sep 2026
Director
Sold on a plan
5,000
$9.10
$45.50K
Maximo F Nougues
6 Jul 2026
Chief Financial Officer
Sold on a plan
9,386
$8.26
$77.56K
Douglas M Hunt
6 Jul 2026
See Remarks
Sold on a plan
8,460
$8.26
$69.90K
Alan H Auerbach
6 Jul 2026
President and CEO
Sold on a plan
44,058
$8.26
$364.05K
Allison Dorval
12 Jun 2026
Director
Sold on a plan
11,610
$7.20
$83.58K
Jay M Moyes
12 Jun 2026
Director
Sold on a plan
22,000
$7.22
$158.80K
Adrian Senderowicz
12 Jun 2026
Director
Sold on a plan
27,000
$7.20
$194.31K
Brian M Stuglik
12 Jun 2026
Director
Sold on a plan
8,100
$7.20
$58.31K
Troy Edward Wilson
12 Jun 2026
Director
Sold on a plan
10,800
$7.20
$77.75K
Maximo F Nougues
7 Jan 2026
Chief Financial Officer
Sold on a plan
6,405
$5.88
$37.65K
Douglas M Hunt
7 Jan 2026
See Remarks
Sold on a plan
5,014
$5.88
$29.48K
Alan H Auerbach
7 Jan 2026
President and CEO
Sold on a plan
18,012
$5.88
$105.89K
Maximo F Nougues
6 Jan 2026
Chief Financial Officer
Sold on a plan
4,540
$5.84
$26.53K
Douglas M Hunt
6 Jan 2026
See Remarks
Sold on a plan
3,973
$5.84
$23.22K
Alan H Auerbach
6 Jan 2026
President and CEO
Sold on a plan
16,938
$5.84
$98.99K
Michael Patrick Miller
11 Nov 2025
Director
Sell
20,000
$4.86
$97.23K

What was left out

Form 4 filings counted 19
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 1
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 494,911
History held since 6 Oct 2011